Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish…

There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an…

After almost 20 years with AbbVie, Renaud Decroix still feels as engaged and motivated as ever by the goal of having a remarkable impact on patients'…

Life sciences have been steadily losing ground in the UK with a significant drop in global R&D investments and a decreasing number of patients…

The top 20 pharmaceutical companies in the world for the past year, according to Pharmaceutical Executive's latest annual rankings. Pfizer holds sway…

A vibrant and diverse continent, home to over 650 million people and the highest life expectancy among developing regions, Latin America is now…

In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin American…

In light of ongoing geopolitical tension, a globally unfavourable macroeconomic environment and new drug-pricing legislation in the US, at the recent…

Latin America is renowned for its creative geniuses – think footballers like Lionel Messi and Pelé; magical realist authors such as Gabriel García…

Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma's bid for…

A roundup of the latest UK healthcare, pharma and biotech news including AbbVie and Lilly's departure from the country's voluntary medicines pricing…

Three country managers with a recent experience of bringing new products from their company's global portfolio into Egypt – and with big plans for…